Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study

BACKGROUND: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) disease. Adiponectin is involved in the metabolism of glucose and lipids with favourable effects on CV disease, especially its high molecular weight (HMW) isoform. Body composition changes are described...

Descripción completa

Detalles Bibliográficos
Autores principales: Toussirot, Eric, Marotte, Hubert, Mulleman, Denis, Cormier, Grégoire, Coury, Fabienne, Gaudin, Philippe, Dernis, Emmanuelle, Bonnet, Christine, Damade, Richard, Grauer, Jean-Luc, Abdesselam, Tassadit Ait, Guillibert-Karras, Caroline, Lioté, Frédéric, Hilliquin, Pascal, Sacchi, Antoinette, Wendling, Daniel, Le Goff, Benoît, Puyraveau, Marc, Dumoulin, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523335/
https://www.ncbi.nlm.nih.gov/pubmed/32993784
http://dx.doi.org/10.1186/s13075-020-02297-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523335/
https://www.ncbi.nlm.nih.gov/pubmed/32993784
http://dx.doi.org/10.1186/s13075-020-02297-7

Ejemplares similares